Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Daisy Alapat

Concepts (246)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
27
2024
2929
1.780
 Why?
Flow Cytometry
5
2018
476
0.900
 Why?
Immunoglobulins
2
2018
79
0.720
 Why?
Immunoglobulin kappa-Chains
2
2016
22
0.650
 Why?
Bone Marrow
7
2022
362
0.600
 Why?
DNA, Neoplasm
1
2018
147
0.590
 Why?
Hematopoietic Stem Cell Transplantation
4
2024
565
0.560
 Why?
Lymphoma, Large B-Cell, Diffuse
2
2015
105
0.550
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2016
55
0.520
 Why?
Immunoglobulin lambda-Chains
1
2015
15
0.520
 Why?
Gene Rearrangement, B-Lymphocyte
1
2015
6
0.500
 Why?
Receptors, Antigen, B-Cell
1
2015
7
0.500
 Why?
Plasma Cells
2
2016
223
0.470
 Why?
Neoplasm, Residual
5
2022
165
0.460
 Why?
Plasmacytoma
3
2022
42
0.410
 Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2012
10
0.400
 Why?
Lymphoma, Mantle-Cell
1
2012
18
0.400
 Why?
Cell Differentiation
1
2015
651
0.400
 Why?
Carcinoembryonic Antigen
1
2011
14
0.380
 Why?
Humans
46
2024
49974
0.380
 Why?
Calcitonin
1
2011
30
0.380
 Why?
Antigens, CD
1
2012
219
0.370
 Why?
Carcinoma
1
2011
138
0.340
 Why?
Myogenin
1
2008
6
0.330
 Why?
Muscle Fibers, Slow-Twitch
1
2008
12
0.330
 Why?
Muscle Fibers, Fast-Twitch
1
2008
14
0.330
 Why?
Monoclonal Gammopathy of Undetermined Significance
2
2022
103
0.320
 Why?
Paraproteinemias
2
2022
72
0.310
 Why?
Middle Aged
17
2024
12069
0.290
 Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
989
0.290
 Why?
Neoplasms, Second Primary
2
2019
78
0.270
 Why?
Tumor Microenvironment
3
2023
212
0.260
 Why?
Prognosis
7
2024
1942
0.260
 Why?
Gene Expression Profiling
3
2016
1032
0.260
 Why?
Treatment Outcome
10
2022
5141
0.250
 Why?
Pancytopenia
3
2016
37
0.240
 Why?
Gastrointestinal Neoplasms
1
2022
44
0.200
 Why?
Aged
15
2024
9310
0.200
 Why?
Female
19
2024
26472
0.200
 Why?
Embolization, Therapeutic
2
2021
88
0.200
 Why?
Neoplasms, Plasma Cell
2
2020
37
0.200
 Why?
Male
16
2024
25241
0.200
 Why?
Thrombocytopenia
1
2022
85
0.190
 Why?
Cryosurgery
1
2021
36
0.190
 Why?
Chromosome Deletion
2
2023
140
0.190
 Why?
Skin Neoplasms
2
2016
488
0.180
 Why?
Transplantation, Autologous
4
2024
466
0.180
 Why?
Combined Modality Therapy
1
2021
637
0.170
 Why?
Ploidies
1
2018
11
0.150
 Why?
Hematopoietic Stem Cells
1
2019
184
0.150
 Why?
Leukemia, Myeloid, Acute
1
2019
185
0.150
 Why?
Kidney Diseases
1
2020
214
0.150
 Why?
Herpesvirus 8, Human
1
2019
91
0.150
 Why?
Sarcoma, Myeloid
1
2017
20
0.140
 Why?
Chromosomes, Human, Pair 17
1
2017
36
0.140
 Why?
Immunohistochemistry
3
2016
973
0.140
 Why?
Lymph Nodes
2
2019
260
0.140
 Why?
Amyloidosis
2
2016
79
0.140
 Why?
Cell Cycle
1
2018
231
0.140
 Why?
CA-125 Antigen
1
2016
17
0.140
 Why?
Skin Diseases, Infectious
1
2016
8
0.140
 Why?
Leukemia, Promyelocytic, Acute
1
2016
11
0.140
 Why?
Anemia, Aplastic
1
2016
12
0.130
 Why?
Myeloproliferative Disorders
1
2016
27
0.130
 Why?
Tumor Suppressor Protein p53
1
2017
202
0.130
 Why?
Electrophoresis, Capillary
1
2015
11
0.130
 Why?
In Situ Hybridization
1
2015
65
0.130
 Why?
V(D)J Recombination
1
2015
4
0.130
 Why?
Immunophenotyping
1
2015
109
0.130
 Why?
RNA, Messenger
2
2015
1105
0.120
 Why?
Diagnosis, Differential
3
2016
1037
0.120
 Why?
Fatal Outcome
1
2015
195
0.120
 Why?
Bone Marrow Transplantation
2
2022
116
0.120
 Why?
Immunoglobulin Light Chains
1
2015
81
0.120
 Why?
Prealbumin
1
2014
21
0.120
 Why?
Bone Marrow Neoplasms
1
2014
13
0.120
 Why?
Neoplasm Proteins
1
2016
322
0.120
 Why?
Hodgkin Disease
1
2014
44
0.110
 Why?
Polymerase Chain Reaction
1
2015
453
0.110
 Why?
Adult
8
2024
13236
0.110
 Why?
Parvoviridae Infections
1
2013
20
0.110
 Why?
Parvovirus B19, Human
1
2013
17
0.110
 Why?
Partial Thromboplastin Time
1
2012
12
0.110
 Why?
Prothrombin Time
1
2012
18
0.110
 Why?
Cardiomyopathies
1
2014
108
0.110
 Why?
Immunoglobulins, Intravenous
1
2013
54
0.110
 Why?
Afibrinogenemia
1
2012
5
0.110
 Why?
Predictive Value of Tests
1
2015
903
0.110
 Why?
Plasma Exchange
1
2012
23
0.100
 Why?
Phenotype
1
2015
729
0.100
 Why?
Retroperitoneal Neoplasms
1
2012
18
0.100
 Why?
Glycoproteins
1
2012
115
0.100
 Why?
Gene Expression Regulation, Neoplastic
1
2016
828
0.100
 Why?
Precursor Cells, B-Lymphoid
1
2012
8
0.100
 Why?
Longitudinal Studies
2
2024
688
0.100
 Why?
Histoplasma
1
2011
27
0.100
 Why?
Antigens, Fungal
1
2011
24
0.100
 Why?
Immunoenzyme Techniques
1
2011
143
0.100
 Why?
Hepatitis C
1
2012
77
0.100
 Why?
Histoplasmosis
1
2011
50
0.090
 Why?
Carcinoma, Neuroendocrine
1
2011
24
0.090
 Why?
In Situ Hybridization, Fluorescence
3
2023
259
0.090
 Why?
Registries
2
2024
522
0.090
 Why?
Dose-Response Relationship, Drug
2
2016
1376
0.090
 Why?
Splenic Neoplasms
1
2009
2
0.090
 Why?
Disease Progression
3
2022
825
0.090
 Why?
Thyroid Neoplasms
1
2011
110
0.080
 Why?
Gene Expression
1
2012
609
0.080
 Why?
Myelodysplastic Syndromes
1
2009
81
0.080
 Why?
Retrospective Studies
4
2024
6108
0.080
 Why?
Mutagenesis, Site-Directed
1
2008
99
0.080
 Why?
Hemangioma
1
2009
83
0.080
 Why?
Aged, 80 and over
4
2019
3129
0.080
 Why?
Tomography, X-Ray Computed
3
2023
1159
0.080
 Why?
HIV Infections
1
2012
357
0.080
 Why?
Survival Analysis
2
2021
653
0.070
 Why?
Cells, Cultured
2
2008
1573
0.070
 Why?
Protein Processing, Post-Translational
1
2008
171
0.070
 Why?
Stem Cell Transplantation
2
2022
181
0.070
 Why?
Graft vs Host Disease
1
2007
75
0.070
 Why?
Positron-Emission Tomography
2
2021
295
0.070
 Why?
Muscle Proteins
1
2008
303
0.070
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
2005
33
0.060
 Why?
Semaphorin-3A
1
2004
2
0.060
 Why?
Nerve Degeneration
1
2004
24
0.060
 Why?
p38 Mitogen-Activated Protein Kinases
1
2005
96
0.060
 Why?
Acid Anhydride Hydrolases
1
2004
15
0.060
 Why?
Antineoplastic Agents
1
2013
1171
0.060
 Why?
Mitogen-Activated Protein Kinase 3
1
2004
50
0.060
 Why?
Mitogen-Activated Protein Kinase 1
1
2004
51
0.060
 Why?
Muscle, Smooth, Vascular
1
2005
130
0.060
 Why?
Imidazoles
1
2005
119
0.060
 Why?
Ferritins
1
2024
30
0.060
 Why?
Pyridines
1
2005
130
0.060
 Why?
Myeloid Progenitor Cells
1
2023
18
0.060
 Why?
Cost of Illness
1
2024
117
0.060
 Why?
Pyrimidines
1
2005
192
0.060
 Why?
Gene Expression Regulation
1
2008
976
0.060
 Why?
Adrenal Cortex Hormones
1
2023
94
0.050
 Why?
Enzyme Inhibitors
1
2005
391
0.050
 Why?
Chromosomes, Human, Pair 1
1
2023
93
0.050
 Why?
Hippocampus
1
2004
228
0.050
 Why?
Case-Control Studies
2
2019
1131
0.050
 Why?
Cohort Studies
2
2020
1422
0.050
 Why?
Dexamethasone
1
2024
430
0.050
 Why?
Mediastinum
1
2021
22
0.050
 Why?
Gastrointestinal Tract
1
2022
103
0.050
 Why?
Chromosome Aberrations
1
2023
297
0.050
 Why?
Fever
1
2022
114
0.050
 Why?
Vincristine
1
2021
89
0.050
 Why?
Axilla
1
2021
89
0.050
 Why?
T-Lymphocytes
1
2023
338
0.050
 Why?
Neurons
1
2004
460
0.050
 Why?
Prednisone
1
2021
99
0.050
 Why?
Pelvis
1
2021
68
0.050
 Why?
Alzheimer Disease
1
2004
324
0.050
 Why?
Cyclophosphamide
1
2021
165
0.050
 Why?
Signal Transduction
2
2004
1618
0.050
 Why?
Time Factors
2
2017
2903
0.050
 Why?
Radiopharmaceuticals
1
2021
209
0.050
 Why?
Fluorodeoxyglucose F18
1
2021
192
0.050
 Why?
Tumor Burden
1
2020
132
0.040
 Why?
Hospitalization
1
2024
652
0.040
 Why?
Mice
3
2023
5739
0.040
 Why?
Antibodies, Monoclonal
1
2023
459
0.040
 Why?
Doxorubicin
1
2021
233
0.040
 Why?
False Negative Reactions
1
2019
30
0.040
 Why?
Adolescent
1
2011
6356
0.040
 Why?
Herpesvirus 4, Human
1
2019
35
0.040
 Why?
Cell Line, Tumor
1
2023
1403
0.040
 Why?
Epstein-Barr Virus Infections
1
2019
30
0.040
 Why?
Herpesviridae Infections
1
2019
46
0.040
 Why?
Phosphorylation
3
2005
535
0.040
 Why?
Virus Diseases
1
2019
39
0.040
 Why?
Genome, Viral
1
2019
79
0.040
 Why?
DNA, Viral
1
2019
133
0.040
 Why?
Follow-Up Studies
1
2024
2182
0.040
 Why?
Neoplasm Recurrence, Local
1
2022
614
0.040
 Why?
Liver
1
2022
1115
0.030
 Why?
Scleromyxedema
1
2016
4
0.030
 Why?
Schnitzler Syndrome
1
2016
4
0.030
 Why?
Xanthomatosis
1
2016
9
0.030
 Why?
Cryoglobulinemia
1
2016
13
0.030
 Why?
Asymptomatic Diseases
1
2016
36
0.030
 Why?
POEMS Syndrome
1
2016
32
0.030
 Why?
Melphalan
1
2016
174
0.030
 Why?
Disease-Free Survival
1
2016
454
0.030
 Why?
Animals
3
2023
13187
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2015
181
0.030
 Why?
Reed-Sternberg Cells
1
2014
2
0.030
 Why?
HIV Seronegativity
1
2014
3
0.030
 Why?
Karyotype
1
2014
18
0.030
 Why?
Fusion Proteins, bcr-abl
1
2014
20
0.030
 Why?
Cell Division
2
2005
292
0.030
 Why?
Thalidomide
1
2016
377
0.030
 Why?
Heterozygote
1
2014
81
0.030
 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2014
43
0.030
 Why?
Mutation
1
2019
1294
0.030
 Why?
Remission Induction
1
2014
207
0.030
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2015
595
0.030
 Why?
Oligonucleotide Array Sequence Analysis
1
2015
411
0.030
 Why?
Fibrinogen
1
2012
31
0.030
 Why?
Risk Assessment
1
2017
1259
0.030
 Why?
Blood Coagulation
1
2012
56
0.030
 Why?
Survival Rate
1
2015
894
0.030
 Why?
Neoplasm Staging
1
2015
740
0.030
 Why?
Reference Values
1
2012
310
0.030
 Why?
Biopsy
1
2014
584
0.020
 Why?
Antibodies, Fungal
1
2011
4
0.020
 Why?
Mycological Typing Techniques
1
2011
3
0.020
 Why?
Cross Reactions
1
2011
42
0.020
 Why?
Lung Diseases, Fungal
1
2011
31
0.020
 Why?
Immunocompromised Host
1
2011
119
0.020
 Why?
Splenectomy
1
2009
34
0.020
 Why?
Severity of Illness Index
1
2012
945
0.020
 Why?
Sensitivity and Specificity
1
2011
861
0.020
 Why?
Blood Transfusion
1
2009
121
0.020
 Why?
Transplantation, Isogeneic
1
2007
2
0.020
 Why?
Laparoscopy
1
2009
170
0.020
 Why?
Mice, Inbred C3H
1
2007
83
0.020
 Why?
Cyclosporine
1
2007
64
0.020
 Why?
Mice, SCID
1
2007
175
0.020
 Why?
Magnetic Resonance Imaging
1
2014
1537
0.020
 Why?
Models, Animal
1
2007
233
0.020
 Why?
Immunosuppressive Agents
1
2007
221
0.020
 Why?
Macromolecular Substances
1
2004
35
0.020
 Why?
Physical Chromosome Mapping
1
2004
8
0.020
 Why?
tau Proteins
1
2004
26
0.020
 Why?
Genetic Complementation Test
1
2004
47
0.020
 Why?
Epitopes
1
2004
59
0.020
 Why?
Epidermal Growth Factor
1
2004
34
0.020
 Why?
Cricetulus
1
2004
97
0.020
 Why?
Catalytic Domain
1
2004
57
0.020
 Why?
Microtubule-Associated Proteins
1
2004
67
0.010
 Why?
Mutagenesis
1
2004
60
0.010
 Why?
Cricetinae
1
2004
192
0.010
 Why?
Cloning, Molecular
1
2004
185
0.010
 Why?
Intercellular Signaling Peptides and Proteins
1
2004
104
0.010
 Why?
Receptors, Cell Surface
1
2004
122
0.010
 Why?
RNA
1
2004
170
0.010
 Why?
Cell Survival
1
2005
600
0.010
 Why?
Amino Acid Sequence
1
2004
585
0.010
 Why?
Molecular Sequence Data
1
2004
792
0.010
 Why?
Nerve Tissue Proteins
1
2004
193
0.010
 Why?
Mice, Inbred C57BL
1
2007
1816
0.010
 Why?
Cell Line
1
2004
1000
0.010
 Why?
Alapat's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (246) concept(s)
_
Co-Authors Expand Description
See all (39) people
_
Similar People Expand Description
See all (31) people
_
Same Department Expand Description
Search Department